Joel Beatty
Stock Analyst at Baird
(4.53)
# 184
Out of 5,180 analysts
213
Total ratings
48.52%
Success rate
33.36%
Average return
Main Sectors:
Stocks Rated by Joel Beatty
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| DNLI Denali Therapeutics | Maintains: Outperform | $29 → $32 | $19.68 | +62.60% | 3 | Mar 26, 2026 | |
| IMMP Immutep | Downgrades: Neutral | $7 → $1 | $0.37 | +170.27% | 6 | Mar 13, 2026 | |
| DNTH Dianthus Therapeutics | Maintains: Outperform | $67 → $132 | $84.56 | +56.10% | 4 | Mar 10, 2026 | |
| CTNM Contineum Therapeutics | Maintains: Outperform | $14 → $20 | $13.45 | +48.70% | 4 | Mar 6, 2026 | |
| PRAX Praxis Precision Medicines | Maintains: Outperform | $275 → $433 | $319.28 | +35.62% | 3 | Feb 20, 2026 | |
| RARE Ultragenyx Pharmaceutical | Maintains: Outperform | $72 → $47 | $21.42 | +119.42% | 5 | Dec 30, 2025 | |
| JAZZ Jazz Pharmaceuticals | Maintains: Outperform | $160 → $209 | $188.27 | +11.01% | 5 | Nov 18, 2025 | |
| ELF e.l.f. Beauty | Maintains: Outperform | $145 → $125 | $62.30 | +100.64% | 9 | Nov 6, 2025 | |
| AMLX Amylyx Pharmaceuticals | Maintains: Outperform | $10 → $19 | $14.35 | +32.40% | 5 | Oct 16, 2025 | |
| LRMR Larimar Therapeutics | Maintains: Outperform | $10 → $7 | $4.68 | +49.57% | 3 | Sep 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $4 → $6 | $2.61 | +129.89% | 5 | Aug 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $7 → $9 | $35.24 | -74.46% | 6 | Jul 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $28 → $31 | $22.32 | +38.89% | 4 | May 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $38 → $24 | $21.66 | +10.80% | 5 | May 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $680 | $743.12 | -8.49% | 7 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $70 → $66 | $68.75 | -4.00% | 15 | May 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $160 → $162 | $171.78 | -5.69% | 5 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $38 → $41 | $35.05 | +16.98% | 3 | May 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $28 → $32 | $24.82 | +28.93% | 2 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $75 | $71.72 | +4.57% | 1 | Nov 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $72 → $65 | $57.24 | +13.56% | 5 | Oct 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $540 → $240 | $0.24 | +98,828.28% | 3 | May 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $4.5 | $1.66 | +171.08% | 2 | Apr 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $24 → $25 | $15.48 | +61.50% | 3 | Apr 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $32 → $28 | $23.88 | +17.25% | 2 | Oct 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $16 | $1.23 | +1,200.81% | 1 | Jun 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $4 → $1.25 | $1.71 | -26.90% | 2 | May 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $44 | $1.32 | +3,233.33% | 3 | Apr 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $60 → $58 | $62.92 | -7.82% | 6 | Feb 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $18 → $24 | $32.48 | -26.11% | 2 | Nov 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $18 | $7.85 | +129.30% | 3 | Nov 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $9 → $6 | $1.61 | +272.67% | 2 | Aug 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | $36 → $28 | $9.02 | +210.42% | 2 | Mar 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $170 → $175 | $328.73 | -46.76% | 2 | Feb 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $14 | $7.07 | +98.02% | 8 | Jan 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $108 | $22.13 | +388.03% | 10 | Jan 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $80 → $78 | $75.13 | +3.82% | 3 | Aug 10, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $140 → $100 | $20.50 | +387.80% | 2 | Apr 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $480 → $120 | $14.64 | +719.67% | 14 | Apr 1, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $480 → $450 | $4.35 | +10,244.83% | 2 | Mar 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $2.61 | - | 12 | Mar 17, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $19 → $15 | $8.02 | +87.03% | 11 | Sep 24, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | $14 → $11 | $11.13 | -5.66% | 8 | Aug 17, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $2,400 → $1,200 | $0.36 | +334,534.69% | 2 | Aug 17, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $19 | $8.34 | +127.82% | 3 | Nov 10, 2017 |
Denali Therapeutics
Mar 26, 2026
Maintains: Outperform
Price Target: $29 → $32
Current: $19.68
Upside: +62.60%
Immutep
Mar 13, 2026
Downgrades: Neutral
Price Target: $7 → $1
Current: $0.37
Upside: +170.27%
Dianthus Therapeutics
Mar 10, 2026
Maintains: Outperform
Price Target: $67 → $132
Current: $84.56
Upside: +56.10%
Contineum Therapeutics
Mar 6, 2026
Maintains: Outperform
Price Target: $14 → $20
Current: $13.45
Upside: +48.70%
Praxis Precision Medicines
Feb 20, 2026
Maintains: Outperform
Price Target: $275 → $433
Current: $319.28
Upside: +35.62%
Ultragenyx Pharmaceutical
Dec 30, 2025
Maintains: Outperform
Price Target: $72 → $47
Current: $21.42
Upside: +119.42%
Jazz Pharmaceuticals
Nov 18, 2025
Maintains: Outperform
Price Target: $160 → $209
Current: $188.27
Upside: +11.01%
e.l.f. Beauty
Nov 6, 2025
Maintains: Outperform
Price Target: $145 → $125
Current: $62.30
Upside: +100.64%
Amylyx Pharmaceuticals
Oct 16, 2025
Maintains: Outperform
Price Target: $10 → $19
Current: $14.35
Upside: +32.40%
Larimar Therapeutics
Sep 30, 2025
Maintains: Outperform
Price Target: $10 → $7
Current: $4.68
Upside: +49.57%
Aug 13, 2025
Maintains: Outperform
Price Target: $4 → $6
Current: $2.61
Upside: +129.89%
Jul 8, 2025
Maintains: Neutral
Price Target: $7 → $9
Current: $35.24
Upside: -74.46%
May 19, 2025
Maintains: Outperform
Price Target: $28 → $31
Current: $22.32
Upside: +38.89%
May 16, 2025
Downgrades: Neutral
Price Target: $38 → $24
Current: $21.66
Upside: +10.80%
May 13, 2025
Upgrades: Outperform
Price Target: $680
Current: $743.12
Upside: -8.49%
May 7, 2025
Maintains: Outperform
Price Target: $70 → $66
Current: $68.75
Upside: -4.00%
May 6, 2025
Maintains: Outperform
Price Target: $160 → $162
Current: $171.78
Upside: -5.69%
May 2, 2025
Maintains: Outperform
Price Target: $38 → $41
Current: $35.05
Upside: +16.98%
Mar 3, 2025
Maintains: Outperform
Price Target: $28 → $32
Current: $24.82
Upside: +28.93%
Nov 25, 2024
Initiates: Outperform
Price Target: $75
Current: $71.72
Upside: +4.57%
Oct 30, 2024
Maintains: Neutral
Price Target: $72 → $65
Current: $57.24
Upside: +13.56%
May 15, 2024
Maintains: Outperform
Price Target: $540 → $240
Current: $0.24
Upside: +98,828.28%
Apr 30, 2024
Downgrades: Neutral
Price Target: $4.5
Current: $1.66
Upside: +171.08%
Apr 11, 2024
Maintains: Outperform
Price Target: $24 → $25
Current: $15.48
Upside: +61.50%
Oct 3, 2023
Maintains: Outperform
Price Target: $32 → $28
Current: $23.88
Upside: +17.25%
Jun 1, 2023
Initiates: Outperform
Price Target: $16
Current: $1.23
Upside: +1,200.81%
May 2, 2023
Maintains: Outperform
Price Target: $4 → $1.25
Current: $1.71
Upside: -26.90%
Apr 13, 2023
Initiates: Outperform
Price Target: $44
Current: $1.32
Upside: +3,233.33%
Feb 7, 2023
Maintains: Outperform
Price Target: $60 → $58
Current: $62.92
Upside: -7.82%
Nov 18, 2022
Maintains: Outperform
Price Target: $18 → $24
Current: $32.48
Upside: -26.11%
Nov 10, 2022
Downgrades: Underperform
Price Target: $18
Current: $7.85
Upside: +129.30%
Aug 29, 2022
Maintains: Outperform
Price Target: $9 → $6
Current: $1.61
Upside: +272.67%
Mar 3, 2022
Upgrades: Neutral
Price Target: $36 → $28
Current: $9.02
Upside: +210.42%
Feb 12, 2021
Downgrades: Neutral
Price Target: $170 → $175
Current: $328.73
Upside: -46.76%
Jan 14, 2021
Downgrades: Neutral
Price Target: $14
Current: $7.07
Upside: +98.02%
Jan 12, 2021
Downgrades: Neutral
Price Target: $108
Current: $22.13
Upside: +388.03%
Aug 10, 2020
Maintains: Buy
Price Target: $80 → $78
Current: $75.13
Upside: +3.82%
Apr 6, 2020
Maintains: Buy
Price Target: $140 → $100
Current: $20.50
Upside: +387.80%
Apr 1, 2020
Maintains: Buy
Price Target: $480 → $120
Current: $14.64
Upside: +719.67%
Mar 26, 2020
Maintains: Buy
Price Target: $480 → $450
Current: $4.35
Upside: +10,244.83%
Mar 17, 2020
Upgrades: Buy
Price Target: n/a
Current: $2.61
Upside: -
Sep 24, 2019
Maintains: Buy
Price Target: $19 → $15
Current: $8.02
Upside: +87.03%
Aug 17, 2018
Upgrades: Neutral
Price Target: $14 → $11
Current: $11.13
Upside: -5.66%
Aug 17, 2018
Maintains: Neutral
Price Target: $2,400 → $1,200
Current: $0.36
Upside: +334,534.69%
Nov 10, 2017
Maintains: Buy
Price Target: $15 → $19
Current: $8.34
Upside: +127.82%